Research With More Than 44 Thousand Genomes Identifies Rare Genetic Variants in Isolated Communities in the United Kingdom, Where Regional Ancestry and Low Migration Flow Increase the Risk of Hereditary Diseases
A study released in October 2024 indicates that populations in isolated regions of the United Kingdom have genetic variations associated with a higher risk of diseases, reinforcing the link between ancestry, geographic isolation, and public health.
Regions With Greater Genetic Distinction
The genetically most distinct populations were identified in the Shetland and Orkney Islands, where disease-causing variants are more than 100 times more common than in other areas.
These variations correspond to changes in the DNA sequence that make up specific genes, making certain hereditary diseases significantly more frequent in these isolated communities.
-
China Develops Custom 140-Ton Electric Mining Truck with 770 kWh Swappable Battery, Deploys 290 Units in Xinjiang’s Largest Zinc Mine
-
Meta to Launch Arena, a New Prediction App Targeting 3.56 Billion Users, Competing with Polymarket and Kalshi
-
Scientist Challenges Famous Human Evolution Theory, Argues Homo Sapiens Evolved Gradually Over Thousands of Years
-
15-Year-Old American Builds Ocean Generator with PVC Pipe and 3D-Printed Propeller for $12, Wins National Prize, Presents at White House, and Makes Forbes 30 Under 30 List
Other Regional Focuses Identified
Scientists also found populations in North and South Wales, southeastern Scotland, Ireland, and parts of England with variants up to 73 times more common.
The results reinforce the direct relationship between regional ancestry and health, especially in remote communities, according to experts involved in the analysis of genetic data.
Isolation and Hereditary Transmission
Populations in isolated locations tend to have lower genetic diversity than large cities, due to reduced migration flow over consecutive generations.
As a consequence, rare genetic variants may become locally common, being transmitted among family members over time without being initially identified.
Many rare genetic diseases only manifest when a person inherits two copies of the variant, while carriers of just one copy may be unaware of the risk.
Analysis of Genetic Data
The research was conducted by a team led by the University of Edinburgh, which analyzed anonymized genetic data from over 44,000 individuals across 20 regions.
The analysis utilized information from the UK BioBank and the VIKING Genes studies, although not all regions were included due to a lack of data.
Rare Diseases in Shetland
Among residents of the Shetland Islands, six genetic variants associated with diseases were identified, including one linked to Batten disease, a childhood neurodegenerative condition.
It is estimated that one in every 41 residents of the Shetland Islands carries this variant, highlighting the impact of prolonged genetic isolation.
Genetic Islands on the Mainland
The study showed that these so-called genetic islands are not restricted to coastal areas or archipelagos, but are also found in mainland areas of the United Kingdom.
In Wales, nine variants with high frequencies were found, including one linked to a hereditary kidney stone disorder, 44 times more common in South Wales.
The ten analyzed English regions did not show such marked genetic distinctions, possibly due to the absence of significant geographic, cultural, or linguistic barriers.
Still, rare variants showed higher prevalence in areas like Lancashire, Staffordshire, and Nottinghamshire, indicating specific and less-known regional patterns.
Critical Cases Identified
In Lancashire, residents are 73 times more likely to carry a variant associated with Zellweger syndrome, a fatal disease affecting the brain, liver, and kidneys.
The condition usually leads to death within the first year of life, underscoring the severity of the impact of these variants in certain regional communities.
Implications for Public Health
Researchers emphasize the need to expand studies on rare genetic variants throughout the United Kingdom, focusing on historically underrepresented regions.
According to the team, future genetic screening programs should consider locally common variants, adapting genomic medicine strategies to regional realities.
The enrichment of these variants in areas like Shetland, Orkney, and Wales reinforces that genetic screening, already common in Jewish populations, is equally justifiable in other communities.
With information from Institute Genetics.
